Pharvaris Bv Stock EBITDA
| PHVS Stock | USD 21.20 0.05 0.24% |
Pharvaris BV fundamentals help investors to digest information that contributes to Pharvaris' financial success or failures. It also enables traders to predict the movement of Pharvaris Stock. The fundamental analysis module provides a way to measure Pharvaris' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharvaris stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -96.9 M | -92 M |
Pharvaris | EBITDA |
Pharvaris BV Company EBITDA Analysis
Pharvaris' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Pharvaris EBITDA | (96.85 M) |
Most of Pharvaris' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharvaris BV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Pharvaris EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Pharvaris is extremely important. It helps to project a fair market value of Pharvaris Stock properly, considering its historical fundamentals such as EBITDA. Since Pharvaris' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pharvaris' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pharvaris' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Pharvaris Ebitda
Ebitda |
|
According to the company disclosure, Pharvaris BV reported earnings before interest,tax, depreciation and amortization of (96.85 Million). This is 111.04% lower than that of the Biotechnology sector and 196.7% lower than that of the Health Care industry. The ebitda for all United States stocks is 102.48% higher than that of the company.
Pharvaris EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharvaris' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pharvaris could also be used in its relative valuation, which is a method of valuing Pharvaris by comparing valuation metrics of similar companies.Pharvaris is currently under evaluation in ebitda category among its peers.
Pharvaris ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pharvaris' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pharvaris' managers, analysts, and investors.Environmental | Governance | Social |
Pharvaris Fundamentals
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.27 | ||||
| Current Valuation | 774.75 M | ||||
| Shares Outstanding | 54.01 M | ||||
| Shares Owned By Insiders | 9.49 % | ||||
| Shares Owned By Institutions | 87.21 % | ||||
| Number Of Shares Shorted | 813.01 K | ||||
| Price To Book | 3.17 X | ||||
| EBITDA | (96.85 M) | ||||
| Net Income | (98.81 M) | ||||
| Cash And Equivalents | 201.38 M | ||||
| Cash Per Share | 5.96 X | ||||
| Total Debt | 239.1 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 12.85 X | ||||
| Book Value Per Share | 6.16 X | ||||
| Cash Flow From Operations | (91.14 M) | ||||
| Short Ratio | 5.12 X | ||||
| Earnings Per Share | (2.83) X | ||||
| Price To Earnings To Growth | (0.12) X | ||||
| Target Price | 34.52 | ||||
| Number Of Employees | 83 | ||||
| Beta | -3.1 | ||||
| Market Capitalization | 1.14 B | ||||
| Total Asset | 399.02 M | ||||
| Retained Earnings | (266.14 M) | ||||
| Working Capital | 383.25 M | ||||
| Net Asset | 399.02 M |
About Pharvaris Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharvaris BV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharvaris using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharvaris BV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharvaris Stock Analysis
When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.